[9886] in APO News
almighty
daemon@ATHENA.MIT.EDU (Hanna P.Allan)
Thu Feb 22 15:36:49 2007
Date: Thu, 22 Feb 2007 22:36:55 +0200
From: "Hanna P.Allan" <zmx@lawday.co.uk>
To: umoc-interested@mit.edu
--------------070800070402000105000505
Content-Type: text/html; charset=ISO-8859-1
Content-Transfer-Encoding: 7bit
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>
<head>
<meta content="text/html;charset=ISO-8859-1" http-equiv="Content-Type">
</head>
<body bgcolor="#ffffff" text="#000000">
<img alt="aftereffect" src="cid:part1.02070508.08090803@lawday.co.uk"
height="287" width="472"><br>
If your cold does not clear up within a week, or if you develop a rash
or a honking cough, you may have a different viral illness.<br>
Last week, the drug's maker, Hoffman-La Roche Inc. Want to contribute
your own article? gov, FDA officials said in a statement. Griffin
worries that vitamin B-17 is not the only natural treatment for serious
disease being suppressed because of political and financial reasons. "We
all know and dread those first symptoms: the scratchy throat, sneezing,
headache, aching muscles, and congestion. See more articles and news on
medicareTrack news on prescription drug at PharmaceuticalFraud.
Malaria's the second-leading cause of death on the planet. Whether we're
talking about Merck, or Nazi Germany, or the FDA or even the Bush
Administration, it's usually only a few people at the top of these
organizations that deserve to be labeled as evil. "They do that because
they're trying to make a buck, and something that is found in nature,
like Laetrile, cannot be patented," says Griffin.<br>
See more articles and news on medicareTrack news on prescription drug at
PharmaceuticalFraud.<br>
If your cold does not clear up within a week, or if you develop a rash
or a honking cough, you may have a different viral illness. Ethics
education, in fact, may be the ultimate solution to this problem,
because without ethics, we are a soulless economy.<br>
I can show it to you; we're non-toxic at the levels at which it's being
used.<br>
It will use the new data in addition to its own information, they said.
If you read the labels of most of those, it will say, "Do not drink or
eat, it will kill you. That substance is vitamin B-17, also called
Laetrile, and it is a naturally-occurring substance that has been banned
for use in the control of cancer in the United States.<br>
However, those study results have not been publicized.<br>
Most people who have these jobs are intelligent, have good ethics and
try to do a good job.<br>
This core problem, according to Griffin, cannot be solved until we get
the politics out of a lot of other areas as well.<br>
This is Mike Adams, the Health Ranger, offering commentary for Truth
Publishing. We're just finishing a bunch of tests now as a dental water
line disinfectant.<br>
"I've done about a dozen FDA clinical trials. Betty Jean Thomas of
Freeport, who is trying to parse the plans for her mother, who is on
both Medicaid and Medicare, agreed.<br>
The authors of Smart Medicine for Healthier Living say that if a cold
gives you a persistent fever, a hacking cough or a rash, you might have
a more serious viral infection. We respect your privacy.<br>
It can be used in any medical facility as a disinfectant.<br>
At 35, a woman's battle against bone loss begins.<br>
The findings are published online in the Rheumatology Journal. Griffin
worries that vitamin B-17 is not the only natural treatment for serious
disease being suppressed because of political and financial reasons.<br>
And this it how I made my way to an industry of health, healing, and
integrity.<br>
Aspect has pushed for its machines to become a standard feature in
operating rooms, but some doctors have resisted, saying clinical
evidence of BIS monitors' effectiveness was wanting. But there are much
better ways to prevent and treat the common cold, using traditional
non-drug remedies and good solid nutrition. The viral infection and the
immune system's battle against it produce the all-too-familiar symptoms:
sore throat, nasal congestion, runny nose, watery eyes, hacking cough
and sometimes fever.<br>
Goodless decide to find his own manufacturer and run a clinical trial.
So even if somebody finds some other way to make it, they can't match
our energy. 31 to sign up if they want coverage to begin Jan.<br>
At the FDA, there are a few key decision makers at the top who are the
driving force of the agency. We've had 41 cases and three human studies
so far.<br>
When they want to earn some money they box Skin Nutrients.<br>
</body>
</html>
--------------070800070402000105000505
Content-Type: image/gif;
name="swallow.gif"
Content-Transfer-Encoding: base64
Content-ID: <part1.02070508.08090803@lawday.co.uk>
Content-Disposition: inline;
filename="swallow.gif"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--------------070800070402000105000505--